The specialised custom created drug market has some new news. A new drug, created to treat just one patient, has pushed the bounds of personalized medicine and has raised unexplored regulatory and ethical questions whether this is okay to do as there are many patients around the world suffering form the same issue is this not curtailment of their right to have proper medication irrespective of their social or economic status.
The drug i....
Tags : Julia Vitarello, in Longmont, Colo, DNA, RNA ,
comments (0)